Lung Cancer
A Phase 1b/2, Open-label, Randomized Study of Vudalimab in Combination With Chemotherapy or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced Non-small Cell Lung Cancer (XmAb717-06)
- Details
ClinicalTrials.gov ID:
NCT06173505
Diagnosis Type:
NA
USOR Number:
- Address
,
P: